Literature DB >> 27869327

The Selective Serotonin Reuptake Inhibitor Fluoxetine Directly Inhibits Osteoblast Differentiation and Mineralization During Fracture Healing in Mice.

Vivian Bradaschia-Correa1, Anne M Josephson1, Devan Mehta1, Matthew Mizrahi1, Shane S Neibart1, Chao Liu1,2, Oran D Kennedy1,2, Alesha B Castillo1,2, Kenneth A Egol1, Philipp Leucht1,3.   

Abstract

Chronic use of selective serotonin reuptake inhibitors (SSRIs) for the treatment of depression has been linked to osteoporosis. In this study, we investigated the effect of chronic SSRI use on fracture healing in two murine models of bone regeneration. First, we performed a comprehensive analysis of endochondral bone healing in a femur fracture model. C57/BL6 mice treated with fluoxetine, the most commonly prescribed SSRI, developed a normal cartilaginous soft-callus at 14 days after fracture and demonstrated a significantly smaller and biomechanically weaker bony hard-callus at 28 days. In order to further dissect the mechanism that resulted in a smaller bony regenerate, we used an intramembranous model of bone healing and revealed that fluoxetine treatment resulted in a significantly smaller bony callus at 7 and 14 days postinjury. In order to test whether the smaller bony regenerate following fluoxetine treatment was caused by an inhibition of osteogenic differentiation and/or mineralization, we employed in vitro experiments, which established that fluoxetine treatment decreases osteogenic differentiation and mineralization and that this effect is serotonin-independent. Finally, in a translational approach, we tested whether cessation of the medication would result in restoration of the regenerative potential. However, histologic and μCT analysis revealed non-union formation in these animals with fibrous tissue interposition within the callus. In conclusion, fluoxetine exerts a direct, inhibitory effect on osteoblast differentiation and mineralization, shown in two disparate murine models of bone repair. Discontinuation of the drug did not result in restoration of the healing potential, but rather led to complete arrest of the repair process. Besides the well-established effect of SSRIs on bone homeostasis, our study provides strong evidence that fluoxetine use negatively impacts fracture healing.
© 2017 American Society for Bone and Mineral Research. © 2017 American Society for Bone and Mineral Research.

Entities:  

Keywords:  BONE; DEPRESSION; OSTEOBLAST; OSTEOPOROSIS; OSTEOPROGENITOR CELL

Mesh:

Substances:

Year:  2017        PMID: 27869327      PMCID: PMC5395314          DOI: 10.1002/jbmr.3045

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  28 in total

1.  Inhibition of the serotonin (5-hydroxytryptamine) transporter reduces bone accrual during growth.

Authors:  Stuart J Warden; Alexander G Robling; Megan S Sanders; Michael M Bliziotes; Charles H Turner
Journal:  Endocrinology       Date:  2004-11-11       Impact factor: 4.736

Review 2.  The non-antidepressant effects of citalopram: a clinician's perspective.

Authors:  Tomas Richter; Zoltan Paluch; Stefan Alusik
Journal:  Neuro Endocrinol Lett       Date:  2014       Impact factor: 0.765

3.  Wnt proteins promote bone regeneration.

Authors:  Steven Minear; Philipp Leucht; Jie Jiang; Bo Liu; Arial Zeng; Christophe Fuerer; Roel Nusse; Jill A Helms
Journal:  Sci Transl Med       Date:  2010-04-28       Impact factor: 17.956

4.  Effects of commonly used medications on bone tissue mineralisation in SaOS-2 human bone cell line: an in vitro study.

Authors:  M Salai; D Somjen; R Gigi; O Yakobson; S Katzburg; O Dolkart
Journal:  Bone Joint J       Date:  2013-11       Impact factor: 5.082

5.  Micro-computed tomography assessment of the progression of fracture healing in mice.

Authors:  Kevin R O'Neill; Christopher M Stutz; Nicholas A Mignemi; Michael C Burns; Matthew R Murry; Jeffry S Nyman; Jonathan G Schoenecker
Journal:  Bone       Date:  2012-03-17       Impact factor: 4.398

6.  Neurotransmitter action in osteoblasts: expression of a functional system for serotonin receptor activation and reuptake.

Authors:  M M Bliziotes; A J Eshleman; X W Zhang; K M Wiren
Journal:  Bone       Date:  2001-11       Impact factor: 4.398

7.  The effect of fluoxetine on bone regeneration in rat calvarial bone defects.

Authors:  Seyed Hossein Mortazavi; Arash Khojasteh; Hamed Vaziri; Ahad Khoshzaban; Mohsen Vahid Roudsari; Sayyed Hassan Emami Razavi
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol Endod       Date:  2009-03-09

8.  Jagged1 is essential for osteoblast development during maxillary ossification.

Authors:  Cynthia R Hill; Masato Yuasa; Jonathan Schoenecker; Steven L Goudy
Journal:  Bone       Date:  2014-02-01       Impact factor: 4.398

9.  A method for isolating high quality RNA from mouse cortical and cancellous bone.

Authors:  Natalie H Kelly; John C Schimenti; F Patrick Ross; Marjolein C H van der Meulen
Journal:  Bone       Date:  2014-07-26       Impact factor: 4.398

10.  Production of a standard closed fracture in laboratory animal bone.

Authors:  F Bonnarens; T A Einhorn
Journal:  J Orthop Res       Date:  1984       Impact factor: 3.494

View more
  19 in total

1.  Glycosylation of dentin matrix protein 1 is critical for fracture healing via promoting chondrogenesis.

Authors:  Hui Xue; Dike Tao; Yuteng Weng; Qiqi Fan; Shuang Zhou; Ruilin Zhang; Han Zhang; Rui Yue; Xiaogang Wang; Zuolin Wang; Yao Sun
Journal:  Front Med       Date:  2019-05-08       Impact factor: 4.592

2.  Drug-induced osteoporosis/osteomalacia: analysis in the French and Spanish pharmacovigilance databases.

Authors:  Quentin Dardonville; Esther Salguiero; Vanessa Rousseau; Leila Chebane; Jean Luc Faillie; Sophie Gautier; Jean Louis Montastruc; Alfonso Carvajal; Haleh Bagheri
Journal:  Eur J Clin Pharmacol       Date:  2019-08-29       Impact factor: 2.953

3.  Age-related inflammation triggers skeletal stem/progenitor cell dysfunction.

Authors:  Anne Marie Josephson; Vivian Bradaschia-Correa; Sooyeon Lee; Kevin Leclerc; Karan S Patel; Emma Muinos Lopez; Hannah P Litwa; Shane S Neibart; Manasa Kadiyala; Madeleine Z Wong; Matthew M Mizrahi; Nury L Yim; Austin J Ramme; Kenneth A Egol; Philipp Leucht
Journal:  Proc Natl Acad Sci U S A       Date:  2019-03-20       Impact factor: 11.205

4.  Temporary inhibition of the plasminogen activator inhibits periosteal chondrogenesis and promotes periosteal osteogenesis during appendicular bone fracture healing.

Authors:  D Bravo; A M Josephson; V Bradaschia-Correa; M Z Wong; N L Yim; S S Neibart; S N Lee; J Huo; T Coughlin; M M Mizrahi; P Leucht
Journal:  Bone       Date:  2018-04-19       Impact factor: 4.398

5.  Fluoxetine induces direct inhibitory effects on mesenchymal stem cell‑derived osteoprogenitor cells independent of serotonin concentration.

Authors:  Samar M Koura; Mohamed Salama; Mahmoud El-Hussiny; Mahmoud El-Sayed Awad Khalil; Ahmed Lotfy; Samia Ahmed Hassan; Seham Aly Gad Elhak; Mohamed A Sobh
Journal:  Mol Med Rep       Date:  2019-02-01       Impact factor: 2.952

6.  Mechanical Loading Promotes the Expansion of Primitive Osteoprogenitors and Organizes Matrix and Vascular Morphology in Long Bone Defects.

Authors:  Chao Liu; Pamela Cabahug-Zuckerman; Christopher Stubbs; Martin Pendola; Cinyee Cai; Kenneth A Mann; Alesha B Castillo
Journal:  J Bone Miner Res       Date:  2019-02-20       Impact factor: 6.741

Review 7.  Could use of Selective Serotonin Reuptake Inhibitors During Lactation Cause Persistent Effects on Maternal Bone?

Authors:  Samantha R Weaver; Laura L Hernandez
Journal:  J Mammary Gland Biol Neoplasia       Date:  2018-03-30       Impact factor: 2.673

8.  Propranolol Reverses Impaired Fracture Healing Response Observed With Selective Serotonin Reuptake Inhibitor Treatment.

Authors:  Sooyeon Lee; Lindsey H Remark; Daniel B Buchalter; Anne M Josephson; Madeleine Z Wong; Hannah P Litwa; Rivka Ihejirika; Kevin Leclerc; Danielle Markus; Nury L Yim; Ruchi Tejwani; Vivian Bradaschia-Correa; Philipp Leucht
Journal:  J Bone Miner Res       Date:  2020-01-10       Impact factor: 6.741

9.  Peripartum Fluoxetine Reduces Maternal Trabecular Bone After Weaning and Elevates Mammary Gland Serotonin and PTHrP.

Authors:  Samantha R Weaver; Hannah P Fricke; Cynthia Xie; Robert J Lipinski; Chad M Vezina; Julia F Charles; Laura L Hernandez
Journal:  Endocrinology       Date:  2018-08-01       Impact factor: 4.736

10.  The effect of selective serotonin reuptake inhibitors on the human mandible.

Authors:  Aykağan Coşgunarslan; Firdevs Aşantoğrol; Damla Soydan Çabuk; Emin Murat Canger
Journal:  Oral Radiol       Date:  2020-01-02       Impact factor: 1.852

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.